Cargando…
High-Throughput Screening Identifies Inhibitors of the SARS Coronavirus Main Proteinase
The causative agent of severe acute respiratory syndrome (SARS) has been identified as a novel coronavirus, SARS-CoV. The main proteinase of SARS-CoV, 3CL(pro), is an attractive target for therapeutics against SARS owing to its fundamental role in viral replication. We sought to identify novel inhib...
Autores principales: | Blanchard, Jan E., Elowe, Nadine H., Huitema, Carly, Fortin, Pascal D., Cechetto, Jonathan D., Eltis, Lindsay D., Brown, Eric D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7134594/ https://www.ncbi.nlm.nih.gov/pubmed/15489171 http://dx.doi.org/10.1016/j.chembiol.2004.08.011 |
Ejemplares similares
-
Heteroaromatic ester inhibitors of hepatitis A virus 3C proteinase: Evaluation of mode of action
por: Huitema, Carly, et al.
Publicado: (2008) -
Aryl methylene ketones and fluorinated methylene ketones as reversible inhibitors for severe acute respiratory syndrome (SARS) 3C-like proteinase
por: Zhang, Jianmin, et al.
Publicado: (2008) -
Crystal Structures of the Main Peptidase from the SARS Coronavirus Inhibited by a Substrate-like Aza-peptide Epoxide
por: Lee, Ting-Wai, et al.
Publicado: (2005) -
An Episulfide Cation (Thiiranium Ring) Trapped in the Active Site of HAV 3C Proteinase Inactivated by Peptide-based Ketone Inhibitors
por: Yin, Jiang, et al.
Publicado: (2006) -
Enzymatic activity of the SARS coronavirus main proteinase dimer
por: Graziano, Vito, et al.
Publicado: (2006)